Aurora Sheboygan Prices – Carfilzomib 10 Milligrams Intravenous Solution at $310.02
Overview: Carfilzomib is an intravenous medication primarily used in the treatment of multiple myeloma, a cancer of the plasma cells in the blood. At Aurora Medical Center Sheboygan County, a 10-milligram dose of Carfilzomib is priced at $310.02. This fee generally includes the medication itself and its preparation for intravenous administration, but may not cover additional costs such as infusion services, facility fees, or related lab work. Patients are encouraged to request an itemized estimate before treatment to understand all potential charges and discuss insurance coverage or financial assistance options.
Cost Breakdown for Carfilzomib Administration
- Carfilzomib (10 mg): $310.02 per dose
- Infusion services: May be billed separately depending on facility policies
- Facility fees: Additional charges for use of hospital resources and staff
- Lab tests & monitoring: Blood tests or other monitoring may incur extra costs
- Pre- and post-infusion medications: Sometimes required and billed separately
Associated Costs to Consider
- Consultations with oncologists or hematologists
- Imaging studies (e.g., X-rays, MRIs) for disease monitoring
- Other supportive medications to manage side effects
- Potential hospital stays if complications occur
Insurance & Payment Advice
- Contact your insurance provider to confirm coverage for Carfilzomib and related services.
- Request pre-authorization if required by your insurance plan.
- Ask the hospital’s billing department for itemized estimates and inquire about financial assistance programs if needed.
- Clarify what portion of the bill will be your responsibility (copays, deductibles, coinsurance).
Side-Effect Considerations & Recovery Tips
- Common side effects can include fatigue, nausea, anemia, and risk of infections. Notify your care team about any symptoms.
- Stay hydrated and follow all instructions regarding diet and activity during treatment.
- Arrange for transportation, as you may feel fatigued after infusions.
- Keep scheduled follow-up appointments for ongoing monitoring.
Frequently Asked Questions
-
What is Carfilzomib used for?
Carfilzomib is used to treat multiple myeloma, a type of blood cancer affecting plasma cells. -
How is Carfilzomib administered?
It is given as an intravenous (IV) infusion, directly into a vein under medical supervision. -
What does the $310.02 fee cover?
This price is for a single 10-milligram dose of Carfilzomib; it may not include infusion services, facility, or laboratory fees. -
Are there additional costs beyond the medication?
Yes, you may also be billed for infusion administration, facility use, doctor visits, lab tests, and supportive medications. -
Will my insurance cover Carfilzomib treatment?
Cancer treatments are often covered, but coverage and out-of-pocket costs depend on your specific insurance plan. Contact your insurer for details. -
Can I receive financial assistance for this treatment?
Many hospitals and pharmaceutical companies offer financial support programs; ask the billing department or social worker for more information. -
What are the common side effects of Carfilzomib?
Common side effects include fatigue, low blood counts, nausea, diarrhea, and increased risk of infections. -
How often is Carfilzomib given?
The dosing schedule varies depending on your treatment plan; your oncologist will provide details tailored to your needs. -
Do I need to prepare for the infusion?
Your care team will provide specific instructions, such as fasting or holding certain medications, if required. -
What should I do if I experience severe side effects?
Contact your healthcare provider immediately if you experience severe symptoms like chest pain, shortness of breath, or signs of infection. -
How can I get an itemized bill?
Request an itemized estimate and final bill from the hospital’s billing department to review all charges related to your treatment.
Aurora Medical Center Sheboygan County offers a range of medical services, including the administration of Carfilzomib, a medication used in cancer treatment. Carfilzomib is an intravenous solution used primarily for patients with multiple myeloma, a type of blood cancer. At Aurora Sheboygan, the cost for a 10-milligram dose of Carfilzomib is priced at $310.02. This pricing reflects the hospital’s commitment to providing specialized oncology treatments while maintaining transparency in healthcare costs. Patients receiving this treatment can expect a professional and compassionate approach from the medical staff, ensuring that they receive the best possible care during their cancer treatment journey.
What is Carfilzomib used for? – Carfilzomib is used in the treatment of multiple myeloma, a cancer that affects plasma cells in the blood.
How is Carfilzomib administered? – Carfilzomib is administered as an intravenous solution, meaning it is delivered directly into the bloodstream through a vein.
What is the cost of Carfilzomib at Aurora Medical Center Sheboygan County? – The cost for a 10-milligram dose of Carfilzomib at Aurora Medical Center Sheboygan County is $310.02.
Are there any side effects associated with Carfilzomib? – Yes, Carfilzomib may cause side effects such as fatigue, nausea, and low blood cell counts, and patients should discuss potential risks with their healthcare provider.
Is Carfilzomib covered by insurance? – Coverage for Carfilzomib varies by insurance plan, and patients should consult their insurance provider to determine if this treatment is covered under their policy.
How often is Carfilzomib administered? – The frequency of Carfilzomib administration depends on the specific treatment regimen prescribed by the oncologist, typically involving cycles of treatment.
What should patients expect during a Carfilzomib treatment session? – During a Carfilzomib treatment session, patients will receive the medication intravenously in a clinical setting, monitored by healthcare professionals to manage any immediate side effects.
Can Carfilzomib be used in combination with other treatments? – Yes, Carfilzomib is often used in combination with other medications and therapies to enhance its effectiveness in treating multiple myeloma.